Get the latest news on Hepion Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CTRVP performance

Latest Hepion Pharmaceuticals Stock News | OTC:CTRVP | Benzinga

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

HEPION PHARM INC PFD by Hepion Pharmaceuticals, Inc.

Comments

Hepion Pharmaceuticals Stock News

News

Latest Hepion Pharmaceuticals Stock News | OTC:CTRVP | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga